119 related articles for article (PubMed ID: 6778299)
41. Direct evidence of bacterial biofilms in otitis media.
Post JC
Laryngoscope; 2001 Dec; 111(12):2083-94. PubMed ID: 11802002
[TBL] [Abstract][Full Text] [Related]
42. [Influence of otitis media with effusion on perilymph and round window membrane].
Suzuki M; Kawauchi H; Fujiyoshi T; Mogi G
Nihon Jibiinkoka Gakkai Kaiho; 1989 Sep; 92(9):1354-8. PubMed ID: 2585203
[TBL] [Abstract][Full Text] [Related]
43. Acute otitis media increases middle ear susceptibility to nasal injection of Pseudomonas aeruginosa.
Antonelli PJ; Juhn SK; Le CT; Giebink GS
Otolaryngol Head Neck Surg; 1994 Jan; 110(1):115-21. PubMed ID: 8290293
[TBL] [Abstract][Full Text] [Related]
44. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla.
Chung MH; Enrique R; Lim DJ; De Maria TF
Acta Otolaryngol; 1994 Jul; 114(4):415-22. PubMed ID: 7976314
[TBL] [Abstract][Full Text] [Related]
45. Round window membrane and perilymph in experimental otitis media with effusion.
Suzuki M; Kawauchi H; Fujiyoshi T; Mogi G
Ann Otol Rhinol Laryngol; 1989 Dec; 98(12 Pt 1):980-7. PubMed ID: 2589769
[TBL] [Abstract][Full Text] [Related]
46. Sequential analysis of serum proteins in middle ear effusions. A study in rats with experimentally induced serous and purulent otitis media.
Johansson U; Hellström S; Stenfors LE; Stigbrand T
Eur Arch Otorhinolaryngol; 1990; 248(2):63-7. PubMed ID: 2282215
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of arachidonic acid metabolites in experimental rat otitis media with effusion].
Enomoto F; Ichikawa G; Nagaoka I; Yamashita T
Nihon Jibiinkoka Gakkai Kaiho; 1995 Jun; 98(6):959-67. PubMed ID: 7629649
[TBL] [Abstract][Full Text] [Related]
48. Muscarinic stimulation of arachidonic acid release and prostaglandin synthesis in bovine ciliary muscle: prostaglandins induce cyclic AMP formation and muscle relaxation.
Yousufzai SY; Zheng P; Abdel-Latif AA
Exp Eye Res; 1994 May; 58(5):513-22. PubMed ID: 7925688
[TBL] [Abstract][Full Text] [Related]
49. Experimental otitis media with effusion induced by platelet activating factor.
Rhee CK; Jung TT; Miller S; Weeks D
Ann Otol Rhinol Laryngol; 1993 Aug; 102(8 Pt 1):600-5. PubMed ID: 8352483
[TBL] [Abstract][Full Text] [Related]
50. High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in microliter volumes of chinchilla middle ear effusion and serum.
Erdmann GR; Canafax DM; Giebink GS
J Chromatogr; 1988 Dec; 433():187-95. PubMed ID: 3235546
[TBL] [Abstract][Full Text] [Related]
51. Clinical-histopathological correlations in experimental otitis media: implications for silent otitis media in humans.
Giebink GS; Ripley ML; Shea DA; Wright PF; Paparella MM
Pediatr Res; 1985 Apr; 19(4):389-96. PubMed ID: 2987783
[TBL] [Abstract][Full Text] [Related]
52. The levels of IL-1 beta in human middle ear effusions.
Juhn SK; Tolan CT; Garvis WJ; Cross DS; Giebink GS
Acta Otolaryngol Suppl; 1992; 493():37-42. PubMed ID: 1636421
[TBL] [Abstract][Full Text] [Related]
53. Eicosapentaenoic acid inhibits the release of 14C-prostacyclin from a perfused tissue after incorporation of 14C-prostaglandin precursors.
Juan H; Sametz W
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):388-93. PubMed ID: 2993925
[TBL] [Abstract][Full Text] [Related]
54. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
Diven WF; Burckart GJ; Alper CM; Jaffe R; Evans RW; Doyle WJ
Ann Otol Rhinol Laryngol; 1998 Mar; 107(3):199-206. PubMed ID: 9525240
[TBL] [Abstract][Full Text] [Related]
55. Experimental otitis media with effusion induced by middle ear effusion.
Nakata J; Suzuki M; Kawauchi H; Mogi G
Laryngoscope; 1992 Sep; 102(9):1037-42. PubMed ID: 1518349
[TBL] [Abstract][Full Text] [Related]
56. Cytokines in experimental otitis media with effusion.
Johnson MD; Fitzgerald JE; Leonard G; Burleson JA; Kreutzer DL
Laryngoscope; 1994 Feb; 104(2):191-6. PubMed ID: 8302123
[TBL] [Abstract][Full Text] [Related]
57. Studies in permeability of the middle ear mucosa. The feasibility of blocking inflammatory mediators.
Frady RP; Parker WA; Jackson RT
Arch Otolaryngol; 1977 Jan; 103(1):47-51. PubMed ID: 831698
[TBL] [Abstract][Full Text] [Related]
58. Experimental otitis media following middle ear inoculation of nonviable Streptococcus pneumoniae.
Lowell SH; Juhn SK; Giebink GS
Ann Otol Rhinol Laryngol; 1980; 89(5 Pt 1):479-82. PubMed ID: 6776863
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory changes reflected in middle ear effusion in otitis media.
Juhn SK; Jung TT
Auris Nasus Larynx; 1985; 12 Suppl 1():S63-6. PubMed ID: 3835938
[TBL] [Abstract][Full Text] [Related]
60. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media.
Ehrlich GD; Veeh R; Wang X; Costerton JW; Hayes JD; Hu FZ; Daigle BJ; Ehrlich MD; Post JC
JAMA; 2002 Apr; 287(13):1710-5. PubMed ID: 11926896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
